Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021

The 50% plaque reduction neutralization assay (PRNT(50)) has been previously used to assess the neutralization capacity of donor plasma against wild-type and variant of concern (VOC) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging data suggest that plasma with an anti-SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Chan J., Evans, David H., Robbins, Ninette F., Orjuela, Guillermo, Abe, Kento T., Rathod, Bhavisha, Colwill, Karen, Gingras, Anne-Claude, Tuite, Ashleigh, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434250/
https://www.ncbi.nlm.nih.gov/pubmed/37289096
http://dx.doi.org/10.1128/spectrum.05256-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434250/
https://www.ncbi.nlm.nih.gov/pubmed/37289096
http://dx.doi.org/10.1128/spectrum.05256-22

Ejemplares similares